Jay Berkley/AIDS

Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.Pett SL, Spyer M, Haddow LJ, Nhema R, Benjamin LA, Najjuka G, Bilima S, Daud I, Musoro G, Kitabalwa J, Selemani G, Kandie S, Cornelius KM, Katemba C, Berkley JA, Hassan AS, Kityo C, Hakim J, Heyderman RS, Gibb DM, Walker AS, REALITY trial team
AIDS, (2021). 35:585-594

Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.Garcia-Knight MA, Nduati E, Hassan AS, Nkumama I, Etyang TJ, Hajj NJ, Gambo F, Odera D, Berkley JA, Rowland-Jones SL, Urban B
AIDS, (2017). 31:1809-1818

Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.Walson JL, Otieno PA, Mbuchi M, Richardson BA, Lohman-Payne B, Macharia SW, Overbaugh J, Berkley J, Sanders EJ, Chung MH, John-Stewart GC
AIDS, (2008). 22:1601-9